Apollomics Inc. (NASDAQ: APLM) stock jumped 3.87% on Wednesday to $4.29 against a previous-day closing price of $4.13. With 0.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.17 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.6600 whereas the lowest price it dropped to was $3.9998. The 52-week range on APLM shows that it touched its highest point at $49.00 and its lowest point at $3.71 during that stretch. It currently has a 1-year price target of $25.00.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APLM was down-trending over the past week, with a drop of -0.23%, but this was down by -33.49% over a month. Three-month performance dropped to -58.91% while six-month performance fell -57.49%.
Float and Shares Shorts:
At present, 13.43 million APLM shares are outstanding with a float of 1.26 million shares on hand for trading. On Apr 27, 2023, short shares totaled 85810.0, which was 0.10% higher than short shares on Mar 30, 2023. In addition to Dr. Guo-Liang Yu Ph.D. as the firm’s Co-Founder, CEO & Exec. Chairman, Dr. Sanjeev Redkar MBA, Ph.D. serves as its Co-Founder, Pres & Exec. Director.
Through their ownership of 153.47% of APLM’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 3.13% of APLM, in contrast to 17.24% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in APLM with 10.46% of the stake, George Kaiser Family Foundation holds 670,976 shares worth 670,976. A second-largest stockholder of APLM, OrbiMed Advisors LLC, holds 612,561 shares, controlling over 9.55% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in APLM, holding 13,427 shares or 0.21% stake. With a 1.81% stake in APLM, the First Trust Merger Arbitrage Fund is the largest stakeholder. A total of 116,076 shares are owned by the mutual fund manager. The Highland Fds. I – NexPoint Merger, which owns about 1.11% of APLM stock, is the second-largest Mutual Fund holder. It holds 71,084 shares valued at 0.33 million. Fidelity Nasdaq Composite Index F holds 0.21% of the stake in APLM, owning 13,427 shares worth 62301.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. EBITDA for the full year was -$27.35M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for APLM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With APLM analysts setting a high price target of $25.00 and a low target of $25.00, the average target price over the next 12 months is $25.00. Based on these targets, APLM could surge 482.75% to reach the target high and rise by 482.75% to reach the target low. Reaching the average price target will result in a growth of 482.75% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.